Skip to main content
Fig. 3 | Journal of Nanobiotechnology

Fig. 3

From: Chitosan-functionalized lipid-polymer hybrid nanoparticles for oral delivery of silymarin and enhanced lipid-lowering effect in NAFLD

Fig. 3

A Cell morphology after Oil Red O staining. Left panel, blank control HepG2 cells with no treatment of fat emulsion. Right panel, HepG2 fatty liver cells treated with 1% medical fat emulsion (scale bar, 20 μm). B Uptake of nanoparticles by HepG2 fatty liver cells treated with 1% medical fat emulsion. C Confocal laser scanning microscopy images. 1. Uptake of curcumin-loaded LPNs (C-LPNs) by HepG2 fatty liver cells treated with 1% medical fat emulsion; 2. Uptake of curcumin-loaded chitosan modified LPNs (CC-LPNs) by HepG2 fatty liver cells treated with 1% medical fat emulsion; 3. Uptake of C-LPNs by Caco-2 cells; 4. Uptake of CC-LPNs by Caco-2 cells

Back to article page